The Group's principal activities are to manufacture store brand over-the-counter pharmaceutical products and store brand nutritional products. The group operates in three segments: Consumer Healthcare, Rx Pharmaceuticals and Active Pharmaceutical. The Consumer Healthcare segment products are analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, vitamin and nutritional supplement products and it includes the Company's U.S., U.K. and Mexico operations supporting the sale of OTC pharmaceutical and nutritional products. The Prescription (Rx) Pharmaceuticals primary activity is development, manufacture and sale of generic prescription drug products, generally for the U.S. market. The Active Pharmaceutical Ingredients (API) segment Ingredient includes the development & manufacturing of API products in Israel and Germany. On 13-Nov-2008, the Group acquired Unico Holdings Inc and on 06-Oct-2008, Laboratorios Diba, S.A.
Alacra Alerts:
Receive alerts on the latest reports on Perrigo Company
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
